Home> Products> levecertain

{ "products": [ { "_id": "666aa91ac4201222ec349925", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LEVECERTAIN 750 ", "description": "LEVECERTAIN 750 \nLevetiracetam (750mg)\nIntroduction:\n\nLEVECERTAIN 750 contains Levetiracetam (750 mg), a potent antiepileptic medication used to treat various types of seizures, including partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures. Levetiracetam is renowned for its effectiveness in controlling seizures and improving the quality of life for individuals with epilepsy by stabilizing electrical activity in the brain.\nKey Features and Benefits:\n\nSeizure Control: Levetiracetam is highly effective in reducing the frequency and severity of seizures, offering better management of epileptic conditions.\nBroad Spectrum of Action: It is used to treat partial-onset seizures, myoclonic seizures in patients with juvenile myoclonic epilepsy, and primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy.\nNeurostabilization: Levetiracetam works by binding to a specific protein (SV2A) in the brain, which is believed to help stabilize neuronal activity and prevent seizure activity.\nRapid Onset of Action: Levetiracetam has a rapid onset of action, making it suitable for patients who need quick control of seizures.\nImproved Quality of Life: By effectively controlling seizures, Levetiracetam helps improve the overall quality of life for individuals with epilepsy, allowing them to engage more fully in daily activities and reducing the impact of the disorder on their lives.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of LEVECERTAIN 750 (Levetiracetam 750 mg) is 500 mg taken twice daily. The dosage may be gradually increased based on the patient's response to treatment and tolerability.\nMaintenance Dosage: The usual maintenance dose ranges from 1000 mg to 3000 mg per day, divided into two doses. The exact dosage should be determined by a healthcare provider, with adjustments made based on the patient's individual needs.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Levetiracetam at the same times each day to maintain consistent medication levels in the bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/levecertain-750-133585", "price": 199.11, "discountamount": 59.73, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "life", "SV2A", "food", "brain", "water", "lives", "EMAIL", "tablet", "Action", "500 mg", "impact", "750 mg", "3000 mg", "1000 mg", "Benefits", "severity", "patients", "response", "disorder", "two doses", "frequency", "treatment", "same times", "management", "Rapid Onset", "bloodstream", "information", "individuals", "adjustments", "LEVECERTAIN", "sterispharma", "tolerability", "sterisonline", "Introduction", "exact dosage", "Key Features", "effectiveness", "Levetiracetam", "various types", "CALL/WHATSAPP", "quick control", "Initial Dosage", "Broad Spectrum", "Administration", "overall quality", "Seizure Control", "specific protein", "daily activities", "seizure activity", "Improved Quality", "individual needs", "neuronal activity", "myoclonic seizures", "Maintenance Dosage", "Neurostabilization", "electrical activity", "healthcare provider", "epileptic conditions", "typical starting dose", "usual maintenance dose", "partial-onset seizures", "juvenile myoclonic epilepsy", "consistent medication levels", "idiopathic generalized epilepsy", "potent antiepileptic medication", "primary generalized tonic-clonic seizures" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1850, "imageuri": "https://productimages.withfloats.com/actual/666aa91d844f2600246899c8.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666aa91d844f2600246899c8.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T08:08:58.02Z", "updatedon": "2024-06-26T10:55:42.264Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/levecertain-750-/1850", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LEVECERTAIN 750 ", "category": "NEUROLOGYRANGE", "tags": [ "levetiracetam 750 mg price", "levetiracetam 750 mg", "levetiracetam 750 mg uses", "levetiracetam warnings", "levetiracetam warnings for dogs" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666aa7b870774b1f84f68bd9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LEVECERTAIN 500 ", "description": "LEVECERTAIN 500 \nLevetiracetam (500mg)\nIntroduction:\n\nLEVECERTAIN 500 contains Levetiracetam (500 mg), a potent antiepileptic medication used to treat various types of seizures, including partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures. Levetiracetam is recognized for its effectiveness in controlling seizures and improving the quality of life for individuals with epilepsy by stabilizing electrical activity in the brain.\nKey Features and Benefits:\n\nSeizure Control: Levetiracetam is highly effective in reducing the frequency and severity of seizures, offering better management of epileptic conditions.\nBroad Spectrum of Action: It is used to treat partial-onset seizures, myoclonic seizures in patients with juvenile myoclonic epilepsy, and primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy.\nNeurostabilization: Levetiracetam works by binding to a specific protein (SV2A) in the brain, which is believed to help stabilize neuronal activity and prevent seizure activity.\nRapid Onset of Action: Levetiracetam has a rapid onset of action, making it suitable for patients who need quick control of seizures.\nImproved Quality of Life: By effectively controlling seizures, Levetiracetam helps improve the overall quality of life for individuals with epilepsy, allowing them to engage more fully in daily activities and reducing the impact of the disorder on their lives.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of LEVECERTAIN 500 (Levetiracetam 500 mg) is 500 mg taken twice daily. The dosage may be gradually increased based on the patient's response to treatment and tolerability.\nMaintenance Dosage: The usual maintenance dose ranges from 1000 mg to 3000 mg per day, divided into two doses. The exact dosage should be determined by a healthcare provider, with adjustments made based on the patient's individual needs.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Levetiracetam at the same times each day to maintain consistent medication levels in the bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/levecertain-500-133584", "price": 129.0, "discountamount": 38.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "life", "food", "SV2A", "EMAIL", "brain", "water", "lives", "impact", "Action", "tablet", "3000 mg", "1000 mg", "Benefits", "severity", "patients", "response", "disorder", "treatment", "frequency", "two doses", "management", "same times", "LEVECERTAIN", "Rapid Onset", "bloodstream", "information", "individuals", "adjustments", "tolerability", "sterispharma", "Introduction", "sterisonline", "exact dosage", "Key Features", "quick control", "CALL/WHATSAPP", "various types", "effectiveness", "Broad Spectrum", "Administration", "Initial Dosage", "Seizure Control", "overall quality", "specific protein", "Improved Quality", "seizure activity", "daily activities", "individual needs", "neuronal activity", "Maintenance Dosage", "myoclonic seizures", "Neurostabilization", "electrical activity", "healthcare provider", "Levetiracetam 500 mg", "epileptic conditions", "typical starting dose", "partial-onset seizures", "usual maintenance dose", "juvenile myoclonic epilepsy", "consistent medication levels", "idiopathic generalized epilepsy", "potent antiepileptic medication", "primary generalized tonic-clonic seizures" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1849, "imageuri": "https://productimages.withfloats.com/actual/666aa7bc0b4fc76a99a2399b.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666aa7bc0b4fc76a99a2399b.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T08:03:04.886Z", "updatedon": "2024-06-26T10:54:45.338Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/levecertain-500-/1849", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LEVECERTAIN 500 ", "category": "", "tags": [ "levetiracetam 500 mg price", "levetiracetam 500 mg uses", "levetiracetam warnings", "levacetam 500 injection uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666aa6b89b27ca0f04a6c39b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LEVECERTAIN 250 ", "description": "LEVECERTAIN 250 \nLevetiracetam (250mg)\nIntroduction:\n\nLEVECERTAIN 250 contains Levetiracetam (250 mg), a potent antiepileptic medication used to treat various types of seizures, including partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures. Levetiracetam is recognized for its effectiveness in controlling seizures and improving the quality of life for individuals with epilepsy by stabilizing electrical activity in the brain.\nKey Features and Benefits:\n\nSeizure Control: Levetiracetam is highly effective in reducing the frequency and severity of seizures, offering better management of epileptic conditions.\nBroad Spectrum of Action: It is used to treat partial-onset seizures, myoclonic seizures in patients\nwith juvenile myoclonic epilepsy, and primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy.\n\nNeurostabilization: Levetiracetam works by binding to a specific protein (SV2A) in the brain, which is believed to help stabilize neuronal activity and prevent seizure activity.\nRapid Onset of Action: Levetiracetam has a rapid onset of action, making it suitable for patients who need quick control of seizures.\nImproved Quality of Life: By effectively controlling seizures, Levetiracetam helps improve the overall quality of life for individuals with epilepsy, allowing them to engage more fully in daily activities and reducing the impact of the disorder on their lives.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of LEVECERTAIN 250 (Levetiracetam 250 mg) is 250 mg taken twice daily. The dosage may be gradually increased based on the patient's response to treatment and tolerability.\nMaintenance Dosage: The usual maintenance dose is 1000 mg to 3000 mg per day, divided into two doses. The exact dosage should be determined by a healthcare provider, with adjustments made based on the patient's individual needs.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Levetiracetam at the same times each day to maintain consistent medication levels in the bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/levecertain-250-133583", "price": 65.0, "discountamount": 19.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "SV2A", "life", "food", "EMAIL", "brain", "water", "lives", "Action", "tablet", "impact", "binding", "1000 mg", "3000 mg", "disorder", "Benefits", "response", "patients", "severity", "two doses", "frequency", "treatment", "management", "same times", "adjustments", "bloodstream", "information", "individuals", "Rapid Onset", "LEVECERTAIN", "tolerability", "sterispharma", "Introduction", "sterisonline", "Key Features", "exact dosage", "quick control", "CALL/WHATSAPP", "various types", "effectiveness", "Broad Spectrum", "Administration", "Initial Dosage", "Seizure Control", "overall quality", "specific protein", "Improved Quality", "daily activities", "individual needs", "seizure activity", "neuronal activity", "Neurostabilization", "Maintenance Dosage", "myoclonic seizures", "electrical activity", "healthcare provider", "Levetiracetam 250 mg", "epileptic conditions", "typical starting dose", "partial-onset seizures", "usual maintenance dose", "juvenile myoclonic epilepsy", "consistent medication levels", "idiopathic generalized epilepsy", "potent antiepileptic medication", "primary generalized tonic-clonic seizures" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1848, "imageuri": "https://productimages.withfloats.com/actual/666aa6ba8b71a2cb2d7cda8e.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666aa6ba8b71a2cb2d7cda8e.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T07:58:48.033Z", "updatedon": "2024-06-26T10:53:33.343Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/levecertain-250-/1848", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LEVECERTAIN 250 ", "category": "NEUROLOGYRANGE", "tags": [ "levetiracetam 250 mg tablet side effects", "levetiracetam 250 mg uses in hindi", "levetiracetam 500 mg price", "levetiracetam 500 mg tablet" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666aa553b6d3f41940ea8c7b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LEVECERTAIN 1000 ", "description": "LEVECERTAIN 1000 \nLevetiracetam (1000mg)\nIntroduction:\n\nLEVECERTAIN 1000 contains Levetiracetam (1000 mg), an antiepileptic medication used to treat various types of seizures, including partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures. Levetiracetam is known for its efficacy in controlling seizures and improving the quality of life for individuals with epilepsy by stabilizing electrical activity in the brain.\nKey Features and Benefits:\n\nSeizure Control: Levetiracetam is highly effective in reducing the frequency and severity of seizures, providing better management of epileptic conditions.\nBroad Spectrum of Action: It is used to treat partial-onset seizures, myoclonic seizures in patients with juvenile myoclonic epilepsy, and primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy.\nNeurostabilization: Levetiracetam works by binding to a specific protein (SV2A) in the brain, which is believed to help stabilize neuronal activity and prevent seizure activity.\nRapid Onset of Action: Levetiracetam has a rapid onset of action, making it suitable for patients who need quick control of seizures.\nImproved Quality of Life: By effectively controlling seizures, Levetiracetam helps improve the overall quality of life for individuals with epilepsy, allowing them to engage more fully in daily activities and reducing the impact of the disorder on their lives.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of LEVECERTAIN 1000 (Levetiracetam 1000 mg) is 500 mg taken twice daily. The dosage may be gradually increased based on the patient's response to treatment and tolerability.\nMaintenance Dosage: The usual maintenance dose is 1000 mg to 3000 mg per day, divided into two doses. The exact dosage should be determined by a healthcare provider.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Levetiracetam at the same times each day to maintain consistent medication levels in the bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/levecertain-1000-133582", "price": 237.0, "discountamount": 71.1, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "SV2A", "food", "life", "EMAIL", "lives", "water", "brain", "impact", "1000mg", "tablet", "500 mg", "better", "Action", "3000 mg", "Benefits", "efficacy", "severity", "patients", "disorder", "response", "two doses", "frequency", "treatment", "management", "same times", "individuals", "bloodstream", "information", "Rapid Onset", "LEVECERTAIN", "Introduction", "tolerability", "sterispharma", "sterisonline", "exact dosage", "Key Features", "various types", "quick control", "CALL/WHATSAPP", "Initial Dosage", "Administration", "Broad Spectrum", "overall quality", "Seizure Control", "Improved Quality", "daily activities", "seizure activity", "specific protein", "neuronal activity", "myoclonic seizures", "Maintenance Dosage", "Neurostabilization", "healthcare provider", "electrical activity", "epileptic conditions", "typical starting dose", "Levetiracetam 1000 mg", "usual maintenance dose", "partial-onset seizures", "antiepileptic medication", "juvenile myoclonic epilepsy", "consistent medication levels", "idiopathic generalized epilepsy", "primary generalized tonic-clonic seizures" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1847, "imageuri": "https://productimages.withfloats.com/actual/666aa5565e294343790db27c.png", "tileimageuri": "https://productimages.withfloats.com/tile/666aa5565e294343790db27c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T07:52:51.537Z", "updatedon": "2024-06-26T10:54:09.789Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/levecertain-1000-/1847", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LEVECERTAIN 1000 ", "category": "NEUROLOGYRANGE", "tags": [ "LEVECERTAIN 1000 mg", "levetiracetam 1000mg side effects", "Levetiracetam 1000mg price", "Levetiracetam (1000mg)", "Levetiracetam (1000mg)" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2025-09-25T10:46:50.098Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d518ce6b4e65282a1dc798", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Formoterol Fumarate Dihydrate Ip 6 mcg & Budesonide IP 400 mcg", "description": "BUDESHINE F 400 CAP - This is a combination inhalation therapy used in the management of asthma and Chronic Obstructive Pulmonary Disease (COPD).\n\n \nMechanism of Action:\n\nFormoterol Fumarate: A long-acting β2-adrenergic agonist (LABA) that relaxes airway smooth muscles, providing rapid and sustained bronchodilation.\n\nBudesonide: An inhaled corticosteroid (ICS) that reduces airway inflammation, swelling, and mucus production.\n\nTogether, they offer dual action—quick relief of bronchospasm and long-term control of airway inflammation.\n\n \n\nIndications:\n\nAsthma (for patients not controlled adequately with inhaled corticosteroids alone).\n\nChronic Obstructive Pulmonary Disease (COPD) with reversible airway obstruction.\n\nPrevention of asthma attacks and reduction of COPD exacerbations.\n\n \n\nKey Benefits:\n\nProvides fast and sustained relief from breathing difficulty.\n\nControls both inflammation and bronchospasm.\n\nReduces the frequency and severity of asthma/COPD flare-ups.\n\nImproves overall lung function and quality of life.\n\n \nDosage and Administration:\n\nAdministered via inhalation as directed by a physician.\n\nDose depends on the severity of disease and patient response.\n\nRegular use is required for effective control—not for acute asthma attacks.\n(Exact dosing schedule to be prescribed by the doctor.)", "price": 238.0, "discountamount": 72.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2181, "imageuri": "https://productimages.withfloats.com/actual/68d518d1c1505f341d018bb1.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d518d1c1505f341d018bb1.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:26:22.554Z", "updatedon": "2025-09-25T10:26:22.554Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/formoterol-fumarate-dihydrate-ip-6-mcg-budesonide-ip-400-mcg/2181", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BUDESHINE F 400 CAP", "category": "ASTHMA RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d2786bf4017fefeee0b981", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ketorolac tromethamine dispersible tablets 10 mg", "description": "KEYPROFEN DT is a fast-acting nonsteroidal anti-inflammatory drug (NSAID) used to relieve moderate pain and inflammation. Its dispersible tablet form ensures quick dissolution and faster pain relief, making it convenient for oral administration. Ideal for managing post-operative pain, musculoskeletal discomfort, and other short-term pain conditions.", "price": 166.0, "discountamount": 49.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2180, "imageuri": "https://productimages.withfloats.com/actual/68d2786fd0799a6bd13134e7.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d2786fd0799a6bd13134e7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-23T10:37:31.507Z", "updatedon": "2025-09-23T10:37:31.507Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ketorolac-tromethamine-dispersible-tablets-10-mg/2180", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "KEYPROFEN DT", "category": "GENERAL RANGE", "tags": [ "KEYPROFEN DT", "ketorolac tromethamine dispersible tablets 10 mg uses in hindi", "ketorolac tromethamine dispersible tablets 10 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68c29ba02244c906e7790e2b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TELAVINCE 300", "description": "TELAVINCE 300 is a high-quality antiviral medication containing Tenofovir Disoproxil Fumarate 300 mg, specifically formulated for the effective management of HIV-1 infection and chronic Hepatitis B in adults and adolescents. Manufactured under strict pharmaceutical standards, TELAVINCE 300 offers consistent, potent, and clinically proven antiviral action, helping to suppress viral replication and improve immune function.\n\nTenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI). It works by interfering with the enzyme reverse transcriptase, which is essential for viral replication in HIV and Hepatitis B viruses. By inhibiting this enzyme, TELAVINCE 300 reduces the amount of virus in the body, helping to prevent further immune system damage and liver complications.\n\n \nKey Indications:\n \n\nTELAVINCE 300 is indicated for:\n\nHIV-1 Infection: In combination with other antiretroviral agents for the treatment of HIV-1 in adults and adolescents (aged 12 years and older, weighing at least 35 kg).\n\nChronic Hepatitis B: For the treatment of chronic hepatitis B virus infection in adults and adolescents with compensated liver disease and evidence of active viral replication.\n\n \nMechanism of Action:\n \nTenofovir Disoproxil Fumarate is a prodrug of tenofovir, which, once absorbed and metabolized in the body, is converted into tenofovir diphosphate, the active form. Tenofovir diphosphate acts as a competitive inhibitor of reverse transcriptase, incorporating itself into the viral DNA chain and causing premature chain termination. This process disrupts the life cycle of the virus, significantly reducing its ability to multiply and spread.\n\n \nDosage and Administration:\n \n\nRecommended Dose for Adults and Adolescents (≥12 years, ≥35 kg): One tablet (300 mg) once daily, preferably with food.\n\nFor HIV Treatment: Administer in combination with other antiretroviral medications as per the treatment regimen.\n\nFor Chronic Hepatitis B: Monotherapy or as part of combination therapy, depending on patient condition and physician's assessment.\n\nDosage adjustments may be required in patients with renal impairment. Close monitoring is recommended for patients with existing kidney disease.\n\n \nKey Benefits of TELAVINCE 300:\n \n\nPotent Antiviral Action: Rapid and sustained suppression of HIV and HBV replication.\nOnce-Daily Dosing: Improves patient compliance and treatment adherence.\n\nBacked by Clinical Research: Proven efficacy in managing viral load and improving immune markers (CD4 count).\n\nTrusted Quality: Manufactured under GMP-certified facilities with stringent quality control processes.\n\nPart of First-Line Therapy: Recommended in various national and international treatment guidelines for HIV and Hepatitis B.\n\n \nSafety and Precautions:\n \n\nRenal Monitoring: Tenofovir may affect kidney function. Routine renal function tests are recommended before and during treatment.\n\nBone Mineral Density: Long-term use may reduce bone mineral density. Consider monitoring in patients at risk of osteopenia or osteoporosis.\n\nHepatic Flare: Discontinuation of therapy in hepatitis B patients may result in severe acute exacerbations. Liver function should be closely monitored post-treatment.\n\nLactic Acidosis and Hepatomegaly: Rare but serious side effects. Patients presenting symptoms such as abdominal pain, fatigue, or difficulty breathing should seek immediate medical attention.\n\n \n\nPossible Side Effects:\n \n\nMost patients tolerate TELAVINCE 300 well. However, some may experience:\n\nNausea\n\nDiarrhea\n\nHeadache\n\nFatigue\n\nRash\n\nDizziness\n\nDecreased bone mineral density\n\nRenal impairment (in rare cases)\n\nIf any side effects persist or worsen, consult a healthcare professional immediately.\n\n \nStorage Instructions:\n \n\nStore in a cool, dry place below 30°C.\n\nProtect from light and moisture.\n\nKeep out of reach of children.\n\n \n\nWhy Choose TELAVINCE 300?\n \n\nTELAVINCE 300 offers a dependable, clinically validated solution for the long-term management of HIV and Hepatitis B. With its once-daily dosing and proven effectiveness, TELAVINCE 300 is an ideal choice for patients and healthcare providers looking for quality, safety, and therapeutic reliability. It is manufactured by a trusted name in healthcare, ensuring every tablet meets global pharmaceutical standards.\n\n \nDisclaimer:\n \n\nThis product description is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or healthcare provider before starting any medication.", "price": 1480.0, "discountamount": 444.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2179, "imageuri": "https://productimages.withfloats.com/actual/68c29ba3794abb27ab248d73.png", "tileimageuri": "https://productimages.withfloats.com/tile/68c29ba3794abb27ab248d73.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-11T09:51:28.508Z", "updatedon": "2025-09-11T09:51:28.508Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/telavince-300/2179", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Tenofovir Disoproxil Fumarate Tablets ip 300 mg", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68beb577cb617ef27c577d94", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CEPHODOXIAA 50 DS", "description": "CEPHODOXIAA 50 DS is an oral suspension containing Cefpodoxime Proxetil, a third-generation cephalosporin antibiotic. It is widely prescribed for the treatment of bacterial infections in adults and children, including infants and babies.Oral suspension form is particularly useful for children and patients who have difficulty swallowing tablets, ensuring accurate dosing and better compliance.\nComposition\nActive Ingredient: Cefpodoxime Proxetil 50 mg per 5 ml suspension\nBrand Name: CEPHODOXIAA 50 DS\nForm: Oral Suspension\nDrug Class: Cephalosporin Antibiotic\nExcipients: Flavors, sweeteners, stabilizers for palatability and suspension stability\nCefpodoxime Proxetil Oral Suspension IP Uses\nCEPHODOXIAA 50 DS is prescribed for a wide variety of bacterial infections:\nRespiratory Tract Infections\nTonsillitis, Pharyngitis\nBronchitis and Pneumonia\nEar, Nose & Throat (ENT) Infections\nAcute Sinusitis\nOtitis Media (middle ear infection)\nUrinary Tract Infections (UTIs)\nCystitis and kidney infections\nSkin & Soft Tissue Infections\nImpetigo, Cellulitis\nInfected wounds and abscesses\nOther Indications\nGonorrhea (in selected cases)\nPediatric bacterial infections where oral dosing is preferred\nFor babies and children: The oral suspension allows precise weight-based dosing, making it safe and convenient for pediatric infections.\nHow Cefpodoxime Proxetil Oral Suspension Works\nCefpodoxime Proxetil is a beta-lactam antibiotic that:\nInhibits bacterial cell wall synthesis\nWeakens bacterial cells, causing cell death\nEffective against both Gram-positive and Gram-negative bacteria\nThis mechanism helps control infections and prevents their spread.\nDosage & Administration \nInfants & Children: Dose is based on body weight and prescribed by a pediatrician.\nCommonly 5–10 mg/kg/day, divided into 2 doses daily.\nAdults: Typically 100–200 mg every 12 hours, depending on infection severity.\nAdministration Tips:\nShake the bottle well before use.\nUse the measuring cup or spoon provided for accurate dosing.\nCan be taken with or without food, but giving after meals may reduce stomach upset.\nComplete the full course even if symptoms improve.\nBenefits of Cefpodoxime Proxetil Oral Suspension\nEasy to administer for children and babies\nBroad-spectrum coverage for respiratory, urinary, and skin infections\nHelps in rapid infection control\nSafe and effective with minimal side effects when taken as prescribed\nSuspension form allows accurate weight-based dosing\nSide Effects of Cefpodoxime Proxetil Oral Suspension\nMild side effects may include:\nDiarrhea or loose stools\nNausea or vomiting\nStomach pain\nHeadache or dizziness\nSkin rash or itching\nSerious side effects (rare):\nSevere allergic reaction (swelling, rash, difficulty breathing)\nSevere diarrhea indicating Clostridium difficile infection\nLiver enzyme elevation\nSeek medical attention if any severe or persistent side effects occur.\nPrecautions & Warnings\nAvoid if allergic to cephalosporins, penicillin, or other beta-lactam antibiotics\nUse cautiously in patients with kidney or liver disease\nNot effective against viral infections like flu or common cold\nPregnant or breastfeeding women should consult a doctor before use\nAlways complete the full prescribed course to prevent antibiotic resistance\nDrug Interactions\nAntacids containing magnesium or aluminum may reduce absorption\nProton pump inhibitors (PPIs) like omeprazole\nBlood thinners (e.g., warfarin – monitor for increased bleeding risk)\nOther antibiotics may interact and alter effectiveness\nConclusion\nCEPHODOXIAA 50 DS (Cefpodoxime Proxetil Oral Suspension IP) is a safe and effective solution for treating bacterial infections in adults, children, and babies.", "price": 100.0, "discountamount": 30.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2178, "imageuri": "https://productimages.withfloats.com/actual/68beb57bed36b14275f756c2.png", "tileimageuri": "https://productimages.withfloats.com/tile/68beb57bed36b14275f756c2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-08T10:52:39.162Z", "updatedon": "2025-09-08T10:52:39.162Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cephodoxiaa-50-ds/2178", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "cefpodoxime proxetil oral suspension ip 50 mg", "category": "Pediatric", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }